Bio pharmaceutical company: ADMA Biology, Inc. (ADMA)

ADMA Biology, Inc. (NASDAQ: ADMA), a biological products company, was founded in 2004. Headquartered in Ramsey, New Jersey, the United States, it has 313 full-time employees Biopharmaceutical Company , committed to the research, development, manufacturing and marketing of plasma biological agents for the treatment and prevention of infectious diseases, and operated ADMA BioCenters blood collection center.

The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/adma.html

ADMA Biology, Inc. (ADMA)

ADMA Biology, Inc., a biopharmaceutical and special immunoglobulin company, is committed to the development, production and marketing of special plasma derived biological agents for the treatment of immunodeficiency and infectious diseases. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/adma.html

ADMA Biology is a professional immunoglobulin company, which mainly develops and manufactures plasma preparations for the treatment and prevention of certain infectious diseases. The target population is targeted at patients suffering from potential immunodeficiency diseases that lead to immune impairment and medical factors that lead to immunosuppression. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/adma.html

The main candidate product of ADMA Biology is RI-002 from human plasma, which has completed the phase III clinical trial for the treatment of primary immunodeficiency disease. RI-002 is an injectable immunoglobulin derived from human plasma rich in naturally occurring polyclonal antibodies and high-level antibodies against respiratory syncytial virus, which is used for the treatment of primary immunodeficiency diseases. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/adma.html

In addition, ADMA Biology also provides Nabi HB, a hyperimmunoglobulin used to treat acute exposure; And Bivigam, an intravenous immunoglobulin for the treatment of primary humoral immune deficiency. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/adma.html

In addition, ADMA Biology also operates source plasma collection facilities (blood collection centers) at Kennesaw in Norcross, Marietta and Georgia. The company is a plasma collection unit licensed by FDA, and provides some plasma to manufacture its pilot candidate product RI-002. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/adma.html

ADMA Biology distributes its products through independent distributors, sales agents, professional pharmacies and other alternative website providers. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/adma.html

ADMA Biology, Inc. (ADMA) US equity investment

• reference material: